Trial · NCT07907601
Registered outcomes46
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 46
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Impact of a targeted and multidisciplinary approach on the quality of life of COPD patients at 12-month follow-up. Control group | Baseline | Difference between the quality-of-life score based on the BPCO-VQ-11 questionnaire given at inclusion and after 12-month follow-up. A first questionnaire will be completed by the patient at inclusion, directly in the care department. A second questionnaire will be completed by the patient at 12 months, during a follow-up visit for consultation with an advanced practice nurse. |
| Primary | Impact of a targeted and multidisciplinary approach on the quality of life of COPD patients at 12-month follow-up. Experimental group | Baseline | Difference between the quality-of-life score based on the BPCO-VQ-11 questionnaire given at inclusion and after 12-month follow-up. A first questionnaire will be completed by the patient at inclusion, directly in the care department. A second questionnaire will be completed by the patient at 12 months, during a follow-up visit for consultation with an advanced practice nurse. |
| Primary | Impact of a targeted and multidisciplinary approach on the quality of life of COPD patients at 12-month follow-up. Control group | At 12 months | Difference between the quality-of-life score based on the BPCO-VQ-11 questionnaire given at inclusion and after 12-month follow-up. A first questionnaire will be completed by the patient at inclusion, directly in the care department. A second questionnaire will be completed by the patient at 12 months, during a follow-up visit for consultation with an advanced practice nurse. |
| Primary | Impact of a targeted and multidisciplinary approach on the quality of life of COPD patients at 12-month follow-up. Experimental group | At 12 months | Difference between the quality-of-life score based on the BPCO-VQ-11 questionnaire given at inclusion and after 12-month follow-up. A first questionnaire will be completed by the patient at inclusion, directly in the care department. A second questionnaire will be completed by the patient at 12 months, during a follow-up visit for consultation with an advanced practice nurse. |
| Secondary | A. Forced Expiratory Volume in 1 second in the control group | Baseline | Spirometry |
| Secondary | A. Forced Expiratory Volume in 1 second in the experimental group | Baseline | Spirometry |
| Secondary | A. Forced Expiratory Volume in 1 second in the control group | At 12 months | Spirometry |
| Secondary | A. Forced Expiratory Volume in 1 second in the experimental group | At 12 months | Spirometry |
| Secondary | B.Dyspnea in the control group according to the Modified Medical Research Council (mMRC) scale in the control group | Baseline | The Modified Medical Research Council (mMRC) scale is a self-administered scale ranging from 0 to 4, by means of which patients evaluate their breathlessness as follows: 0 I only get breathless with strenuous exercise 1. I get short of breath when hurrying on level ground or walking up a slight hill 2. On level ground, I walk slower than people of the same age because of breathlessness, or have to stop for breath when walking at my own pace 3. I stop for breath after walking about 100 yards \[91 meters\] or after a few minutes on level ground 4. I am too breathless to leave the house or I am breathless when dressing |
| Secondary | B.Dyspnea in the control group according to the Modified Medical Research Council (mMRC) scale in the experimental group | Baseline | The Modified Medical Research Council (mMRC) scale is a self-administered scale ranging from 0 to 4, by means of which patients evaluate their breathlessness as follows: 0 I only get breathless with strenuous exercise 1. I get short of breath when hurrying on level ground or walking up a slight hill 2. On level ground, I walk slower than people of the same age because of breathlessness, or have to stop for breath when walking at my own pace 3. I stop for breath after walking about 100 yards \[91 meters\] or after a few minutes on level ground 4. I am too breathless to leave the house or I am breathless when dressing |
| Secondary | B.Dyspnea in the control group according to the Modified Medical Research Council (mMRC) scale in the control group | At 12 months | The Modified Medical Research Council (mMRC) scale is a self-administered scale ranging from 0 to 4, by means of which patients evaluate their breathlessness as follows: 0 I only get breathless with strenuous exercise 1. I get short of breath when hurrying on level ground or walking up a slight hill 2. On level ground, I walk slower than people of the same age because of breathlessness, or have to stop for breath when walking at my own pace 3. I stop for breath after walking about 100 yards \[91 meters\] or after a few minutes on level ground 4. I am too breathless to leave the house or I am breathless when dressing |
| Secondary | B.Dyspnea in the control group according to the Modified Medical Research Council (mMRC) scale in the experimental group | At 12 months | The Modified Medical Research Council (mMRC) scale is a self-administered scale ranging from 0 to 4, by means of which patients evaluate their breathlessness as follows: 0 I only get breathless with strenuous exercise 1. I get short of breath when hurrying on level ground or walking up a slight hill 2. On level ground, I walk slower than people of the same age because of breathlessness, or have to stop for breath when walking at my own pace 3. I stop for breath after walking about 100 yards \[91 meters\] or after a few minutes on level ground 4. I am too breathless to leave the house or I am breathless when dressing |
| Secondary | C. Symptoms of COPD according to the COPD Assessment Test (CAT) score in the control group | Baseline | The COPD Assessment Test (CAT) score is obtained via a questionnaire containing 8 questions regarding the patient's symptoms of COPD graded from 0 (not at all) to 5 (very much). The total score is the sum of the patient's answers to all 8 questions. |
| Secondary | C. Symptoms of COPD according to the COPD Assessment Test (CAT) score in the experimental group | Baseline | The COPD Assessment Test (CAT) score is obtained via a questionnaire containing 8 questions regarding the patient's symptoms of COPD graded from 0 (not at all) to 5 (very much). The total score is the sum of the patient's answers to all 8 questions. |
| Secondary | C. Symptoms of COPD according to the COPD Assessment Test (CAT) score in the control group | At 12 months | The COPD Assessment Test (CAT) score is obtained via a questionnaire containing 8 questions regarding the patient's symptoms of COPD graded from 0 (not at all) to 5 (very much). The total score is the sum of the patient's answers to all 8 questions. |
| Secondary | C. Symptoms of COPD according to the COPD Assessment Test (CAT) score in the experimental group | At 12 months | The COPD Assessment Test (CAT) score is obtained via a questionnaire containing 8 questions regarding the patient's symptoms of COPD graded from 0 (not at all) to 5 (very much). The total score is the sum of the patient's answers to all 8 questions. |
| Secondary | D. Mortality in the control group | At 6 months | Number of deaths |
| Secondary | D. Mortality in the experimental group | At 6 months | Number of deaths |
| Secondary | D. Mortality in the control group | At 12 months | Number of deaths |
| Secondary | D. Mortality in the experimental group | At 12 months | Number of deaths |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07907601/registered